Background: The 2020 consensus guidelines for vancomycin therapeutic monitoring
recommend using Bayesian estimation targeting the ratio of the area under the curve over …

Aims This study aims to investigate prescribing and therapeutic drug monitoring (TDM)
practices for vancomycin in paediatrics at the Jordan University Hospital and to determine …

Introduction Numerous vancomycin population pharmacokinetic (PK) models of neonates
have been published. We aimed to comparatively evaluate a set of these models by …

TO THE E DITOR—We read with interest the recent paper of Patel et al describing the
pharmacokinetic and pharmacodynamic profile of the vancomycin regimens according to the …

Vancomycin is one of the most common antimicrobial agents prescribed for hospitalized
children [1]. Despite decades of clinical experience, consensus guidelines on therapeutic …

Sixty years later, the question that still remains is how to appropriately utilize vancomycin in
the pediatric population. The Infectious Diseases Society of America published guidelines in …

Vancomycin pharmacokinetic (PK) and pharmacodynamic (PD) data in neonates are based
on total concentrations. However, only unbound vancomycin is pharmacologically active …

The objective of the present study was to analyze the pharmacokinetic behavior of
vancomycin in neonates of postconceptional age< or= 32 weeks (n= 44). The elimination of …

Background Vancomycin dosing in neonates is challenging because of the large variation in
pharmacokinetics. Existing empiric dosing recommendations use table-based formats …

Background Correct dosing and therapeutic drug monitoring (TDM) practices are essential
when aiming for optimal vancomycin treatment. Objective To assess target attainment after …